Literature DB >> 33989548

Mechanisms and disease consequences of nonalcoholic fatty liver disease.

Rohit Loomba1, Scott L Friedman2, Gerald I Shulman3.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. Here we provide an in-depth discussion of the underlying pathogenetic mechanisms that lead to progressive liver injury, including the metabolic origins of NAFLD, the effect of NAFLD on hepatic glucose and lipid metabolism, bile acid toxicity, macrophage dysfunction, and hepatic stellate cell activation, and consider the role of genetic, epigenetic, and environmental factors that promote fibrosis progression and risk of hepatocellular carcinoma in NASH.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  fibrosis; insulin resistance; lipotoxicity; liver cancer; metabolism-associated fatty liver disease; nonalcoholic steatohepatitis

Mesh:

Year:  2021        PMID: 33989548     DOI: 10.1016/j.cell.2021.04.015

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  106 in total

1.  Dectin-1 plays a deleterious role in high fat diet-induced NAFLD of mice through enhancing macrophage activation.

Authors:  Min-Xiu Wang; Wu Luo; Lin Ye; Lei-Ming Jin; Bin Yang; Qian-Hui Zhang; Jian-Chang Qian; Yi Wang; Yi Zhang; Guang Liang
Journal:  Acta Pharmacol Sin       Date:  2022-06-10       Impact factor: 6.150

Review 2.  Inflammation in obesity, diabetes, and related disorders.

Authors:  Theresa V Rohm; Daniel T Meier; Jerrold M Olefsky; Marc Y Donath
Journal:  Immunity       Date:  2022-01-11       Impact factor: 31.745

3.  Blockage of NDUFB9-SCD1 pathway inhibits adipogenesis : Blockage of NDUFB9-SCD1 pathway inhibits adipogenesis.

Authors:  Shenglong Zhu; Jingwei Zhang; Wei Wang; Xuan Jiang; Yong Q Chen
Journal:  J Physiol Biochem       Date:  2022-02-05       Impact factor: 4.158

4.  Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH).

Authors:  Z Wang; Z Zhao; Y Xia; Z Cai; C Wang; Y Shen; R Liu; H Qin; J Jia; G Yuan
Journal:  J Endocrinol Invest       Date:  2022-02-28       Impact factor: 4.256

5.  Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease.

Authors:  Naoto Fujiwara; Naoto Kubota; Emilie Crouchet; Bhuvaneswari Koneru; Cesia A Marquez; Arun K Jajoriya; Gayatri Panda; Tongqi Qian; Shijia Zhu; Nicolas Goossens; Xiaochen Wang; Shuang Liang; Zhenyu Zhong; Sara Lewis; Bachir Taouli; Myron E Schwartz; Maria Isabel Fiel; Amit G Singal; Jorge A Marrero; Austin J Fobar; Neehar D Parikh; Indu Raman; Quan-Zhen Li; Masataka Taguri; Atsushi Ono; Hiroshi Aikata; Takashi Nakahara; Hayato Nakagawa; Yuki Matsushita; Ryosuke Tateishi; Kazuhiko Koike; Masahiro Kobayashi; Takaaki Higashi; Shigeki Nakagawa; Yo-Ichi Yamashita; Toru Beppu; Hideo Baba; Hiromitsu Kumada; Kazuaki Chayama; Thomas F Baumert; Yujin Hoshida
Journal:  Sci Transl Med       Date:  2022-06-22       Impact factor: 19.319

Review 6.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

Review 7.  Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications.

Authors:  Nguyen H Tran
Journal:  Curr Oncol Rep       Date:  2022-01-21       Impact factor: 5.075

Review 8.  Intestinal Barrier and Permeability in Health, Obesity and NAFLD.

Authors:  Piero Portincasa; Leonilde Bonfrate; Mohamad Khalil; Maria De Angelis; Francesco Maria Calabrese; Mauro D'Amato; David Q-H Wang; Agostino Di Ciaula
Journal:  Biomedicines       Date:  2021-12-31

9.  Machine learning enables new insights into genetic contributions to liver fat accumulation.

Authors:  Mary E Haas; James P Pirruccello; Samuel N Friedman; Minxian Wang; Connor A Emdin; Veeral H Ajmera; Tracey G Simon; Julian R Homburger; Xiuqing Guo; Matthew Budoff; Kathleen E Corey; Alicia Y Zhou; Anthony Philippakis; Patrick T Ellinor; Rohit Loomba; Puneet Batra; Amit V Khera
Journal:  Cell Genom       Date:  2021-12-08

Review 10.  Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies.

Authors:  Youngmin A Lee; Scott L Friedman
Journal:  J Intern Med       Date:  2021-09-26       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.